Multiple myeloma (MM) is a neoplastic monoclonal proliferation of plasma cells, mainly involving bone marrow. To properly stage and manage patients with MM the clinician needs, at first, a complete skeletal survey, being more rarely present also extra skeletal locations. Today none of the available diagnostic imaging methods is able alone to answer to all the questions regarding staging, treatment, and follow up. Continuing to be alive the role of traditional radiology, implemented information can be added by CT and MRI. Concerning nuclear medicine, bone scintigraphy is affected by its low sensitivity. Tc-99m MIBI has been proposed in staging and in follow up, with most relevant clinical information deriving from the correlation of its whol...
Experience of scintigraphic detection of bone lesion and active bone marrow involvement of multiple ...
New imaging techniques have been introduced to assess the extent and severity of disease in multiple...
Up to 90 % of patients with multiple myeloma develop bone lesions. The lesions are purely osteolytic...
Multiple myeloma (MM) is a neoplastic monoclonal proliferation of plasma cells, mainly involving bon...
International audienceMultiple myeloma is a malignant B-cell neoplasm that involves the skeleton in ...
Bone disease is the hallmark of multiple myeloma. Skeletal lesions are evaluated to establish the di...
Bone disease is the major feature of multiple myeloma (MM). Imaging is required for correct staging,...
International audienceMultiple myeloma (MM) is a hematological neoplasm characterized by the clonal ...
Several imaging technologies are used for the diagnosis and management of patients with multiple mye...
none3noBone disease is the most frequent feature of multiple myeloma (MM) and represents a marker of...
Multiple myeloma (MM) is the second most common hematological malignancy. Although it can affect dif...
peer reviewedA majority of multiple myeloma patients present with osteolytic bone lesions that can c...
Technetium-99m 2-methoxyisobutylisonitrile (99mTc-MIBI) is a lipophilic agent that has been proposed...
Multiple myeloma (MM) is a plasma cell malignancy and is characterized by the presence of lytic bone...
Multiple Myeloma (MM) is a plasma cell disorder, characterized by bone marrow infiltration with clon...
Experience of scintigraphic detection of bone lesion and active bone marrow involvement of multiple ...
New imaging techniques have been introduced to assess the extent and severity of disease in multiple...
Up to 90 % of patients with multiple myeloma develop bone lesions. The lesions are purely osteolytic...
Multiple myeloma (MM) is a neoplastic monoclonal proliferation of plasma cells, mainly involving bon...
International audienceMultiple myeloma is a malignant B-cell neoplasm that involves the skeleton in ...
Bone disease is the hallmark of multiple myeloma. Skeletal lesions are evaluated to establish the di...
Bone disease is the major feature of multiple myeloma (MM). Imaging is required for correct staging,...
International audienceMultiple myeloma (MM) is a hematological neoplasm characterized by the clonal ...
Several imaging technologies are used for the diagnosis and management of patients with multiple mye...
none3noBone disease is the most frequent feature of multiple myeloma (MM) and represents a marker of...
Multiple myeloma (MM) is the second most common hematological malignancy. Although it can affect dif...
peer reviewedA majority of multiple myeloma patients present with osteolytic bone lesions that can c...
Technetium-99m 2-methoxyisobutylisonitrile (99mTc-MIBI) is a lipophilic agent that has been proposed...
Multiple myeloma (MM) is a plasma cell malignancy and is characterized by the presence of lytic bone...
Multiple Myeloma (MM) is a plasma cell disorder, characterized by bone marrow infiltration with clon...
Experience of scintigraphic detection of bone lesion and active bone marrow involvement of multiple ...
New imaging techniques have been introduced to assess the extent and severity of disease in multiple...
Up to 90 % of patients with multiple myeloma develop bone lesions. The lesions are purely osteolytic...